AxoGen, Inc. develops and markets surgical solutions for physical damage or transection to peripheral nerves. They offer a variety of products, including biologically active off-the-shelf processed human nerve allograft, porcine submucosa extracellular matrix (ECM) coaptation aids, and soft tissue membranes to separate tissues in the surgical bed. The company provides its products to various healthcare professionals and military hospitals in multiple countries around the world.